| P50 | author | Takayuki Aoki | Q73502870 |
| | Mariko Naito | Q114019319 |
| P2093 | author name string | Yoshihide Ota | |
| | Takeshi Akiba | |
| | Takatsugu Suzuki | |
| | Yuya Denda | |
| | Toshihiro Arai | |
| | Ken-Ichi Aoyama | |
| P2860 | cites work | Guidance for industry: patient-reported outcome measures: use in medical product development to support labeling claims: draft guidance | Q29615569 |
| | A regulatory perspective on missing data in the aftermath of the NRC report | Q31032578 |
| | Carboplatin plus paclitaxel once a week versus every 3 weeks in patients with advanced ovarian cancer (MITO-7): a randomised, multicentre, open-label, phase 3 trial | Q33413609 |
| | The missing voice of patients in drug-safety reporting | Q34544023 |
| | A structured review and theme analysis of papers published on 'quality of life' in head and neck cancer: 2000-2005. | Q36864792 |
| | Symptom Monitoring With Patient-Reported Outcomes During Routine Cancer Treatment: A Randomized Controlled Trial | Q36914459 |
| | Quality of life in patients treated for cancer of the oral cavity requiring reconstruction: a prospective study | Q37154186 |
| | Head and Neck Cancers, Version 1.2015. | Q37157739 |
| | The truly remarkable universality of half a standard deviation: confirmation through another look | Q37609375 |
| | Methods for interpreting change over time in patient-reported outcome measures | Q38004979 |
| | New frontiers in patient-reported outcomes: adverse event reporting, comparative effectiveness, and quality assessment | Q38165976 |
| | Changes in health-related quality of life of oral cancer patients treated with curative intent: experience of a developing country | Q38894069 |
| | Seeking harmony: estimands and sensitivity analyses for confirmatory clinical trials | Q39974227 |
| | Patient versus clinician symptom reporting using the National Cancer Institute Common Terminology Criteria for Adverse Events: results of a questionnaire-based study | Q40273166 |
| | A standardised, generic, validated approach to stratify the magnitude of clinical benefit that can be anticipated from anti-cancer therapies: the European Society for Medical Oncology Magnitude of Clinical Benefit Scale (ESMO-MCBS). | Q40887724 |
| | Impact of HPV-associated p16-expression on radiotherapy outcome in advanced oropharynx and non-oropharynx cancer. | Q42176105 |
| | A pilot study of the translation, cultural adaptation and validation of the EORTC head and neck cancer quality of life questionnaire module (QLQ-H&N35) for use in Japan | Q47272073 |
| | Psychosocial responses to oral and maxillofacial surgery for head and neck cancer | Q48924459 |
| | Perioperative assessment of psychological state and quality of life of head and neck cancer patients undergoing surgery. | Q50761383 |
| | The impact of cancer and chemotherapy: perceptual similarities and differences between cancer patients, nurses and physicians. | Q50873721 |
| | The Performance Status Scale for Head and Neck Cancer Patients and the Functional Assessment of Cancer Therapy-Head and Neck Scale. A study of utility and validity. | Q51113959 |
| | The concept of clinically meaningful difference in health-related quality-of-life research. How meaningful is it? | Q53501333 |
| | Outcomes of cancer treatment for technology assessment and cancer treatment guidelines. American Society of Clinical Oncology | Q71093095 |
| P433 | issue | 6 | |
| P921 | main subject | lip and oral cavity carcinoma | Q55790434 |
| P304 | page(s) | 1038-1045 | |
| P577 | publication date | 2018-07-25 | |
| P1433 | published in | International Journal of Clinical Oncology | Q15758148 |
| P1476 | title | Longitudinal changes in the quality of life of oral cancer patients during the perioperative period | |
| P478 | volume | 23 | |